塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/07/30 | 6,199 | 6,258 | 6,137 | 6,159 | +4 | +0.1% | 1,147,000 |
2019/07/29 | 6,208 | 6,282 | 6,129 | 6,155 | -54 | -0.9% | 1,321,100 |
2019/07/26 | 6,103 | 6,215 | 6,076 | 6,209 | +104 | +1.7% | 1,043,500 |
2019/07/25 | 6,165 | 6,188 | 6,089 | 6,105 | -90 | -1.5% | 1,467,000 |
2019/07/24 | 6,230 | 6,247 | 6,161 | 6,195 | -66 | -1.1% | 813,300 |
2019/07/23 | 6,247 | 6,306 | 6,217 | 6,261 | -1 | ±0% | 498,200 |
2019/07/22 | 6,177 | 6,271 | 6,123 | 6,262 | +31 | +0.5% | 831,600 |
2019/07/19 | 6,138 | 6,231 | 6,131 | 6,231 | +102 | +1.7% | 684,600 |
2019/07/18 | 6,191 | 6,224 | 6,105 | 6,129 | -86 | -1.4% | 949,000 |
2019/07/17 | 6,150 | 6,218 | 6,145 | 6,215 | +64 | +1% | 603,400 |
2019/07/16 | 6,150 | 6,180 | 6,106 | 6,151 | -22 | -0.4% | 534,200 |
2019/07/12 | 6,279 | 6,291 | 6,121 | 6,173 | -86 | -1.4% | 844,300 |
2019/07/11 | 6,338 | 6,370 | 6,242 | 6,259 | +21 | +0.3% | 704,400 |
2019/07/10 | 6,179 | 6,267 | 6,166 | 6,238 | +58 | +0.9% | 891,600 |
2019/07/09 | 6,242 | 6,265 | 6,160 | 6,180 | -9 | -0.1% | 712,800 |
2019/07/08 | 6,267 | 6,280 | 6,154 | 6,189 | -131 | -2.1% | 873,500 |
2019/07/05 | 6,338 | 6,340 | 6,278 | 6,320 | -14 | -0.2% | 500,200 |
2019/07/04 | 6,388 | 6,405 | 6,319 | 6,334 | +14 | +0.2% | 412,400 |
2019/07/03 | 6,388 | 6,430 | 6,295 | 6,320 | -35 | -0.6% | 718,000 |
2019/07/02 | 6,300 | 6,366 | 6,287 | 6,355 | +40 | +0.6% | 688,000 |
2019/07/01 | 6,237 | 6,339 | 6,195 | 6,315 | +106 | +1.7% | 904,700 |
2019/06/28 | 6,169 | 6,266 | 6,167 | 6,209 | -19 | -0.3% | 876,400 |
2019/06/27 | 6,230 | 6,230 | 6,131 | 6,228 | -63 | -1% | 1,056,800 |
2019/06/26 | 6,221 | 6,304 | 6,198 | 6,291 | +40 | +0.6% | 960,100 |
2019/06/25 | 6,209 | 6,284 | 6,209 | 6,251 | +32 | +0.5% | 792,800 |
2019/06/24 | 6,172 | 6,228 | 6,156 | 6,219 | +69 | +1.1% | 687,000 |
2019/06/21 | 6,133 | 6,198 | 6,120 | 6,150 | +22 | +0.4% | 1,259,500 |
2019/06/20 | 6,206 | 6,235 | 6,124 | 6,128 | -55 | -0.9% | 909,900 |
2019/06/19 | 6,242 | 6,242 | 6,139 | 6,183 | +6 | +0.1% | 1,112,200 |
2019/06/18 | 6,186 | 6,267 | 6,158 | 6,177 | +67 | +1.1% | 1,124,900 |
2019/06/17 | 6,144 | 6,156 | 6,102 | 6,110 | -88 | -1.4% | 721,900 |
2019/06/14 | 6,210 | 6,218 | 6,132 | 6,198 | +52 | +0.8% | 1,476,000 |
2019/06/13 | 6,070 | 6,153 | 6,064 | 6,146 | +85 | +1.4% | 946,400 |
2019/06/12 | 6,068 | 6,094 | 6,031 | 6,061 | +37 | +0.6% | 953,200 |
2019/06/11 | 6,001 | 6,030 | 5,967 | 6,024 | -49 | -0.8% | 758,900 |
2019/06/10 | 6,077 | 6,104 | 6,049 | 6,073 | -3 | ±0% | 953,100 |
2019/06/07 | 6,104 | 6,139 | 6,063 | 6,076 | +36 | +0.6% | 583,400 |
2019/06/06 | 6,101 | 6,114 | 6,024 | 6,040 | -120 | -1.9% | 876,200 |
2019/06/05 | 6,139 | 6,160 | 6,052 | 6,160 | +204 | +3.4% | 1,220,000 |
2019/06/04 | 5,900 | 5,972 | 5,886 | 5,956 | +56 | +0.9% | 1,074,500 |
2019/06/03 | 5,841 | 5,905 | 5,808 | 5,900 | -40 | -0.7% | 1,142,600 |
2019/05/31 | 5,950 | 6,023 | 5,933 | 5,940 | -25 | -0.4% | 1,074,600 |
2019/05/30 | 6,062 | 6,078 | 5,937 | 5,965 | -172 | -2.8% | 1,158,400 |
2019/05/29 | 6,199 | 6,242 | 6,118 | 6,137 | -90 | -1.4% | 971,700 |
2019/05/28 | 6,264 | 6,310 | 6,227 | 6,227 | -22 | -0.4% | 1,611,100 |
2019/05/27 | 6,205 | 6,267 | 6,191 | 6,249 | +33 | +0.5% | 1,226,700 |
2019/05/24 | 6,285 | 6,303 | 6,204 | 6,216 | -158 | -2.5% | 1,397,800 |
2019/05/23 | 6,329 | 6,394 | 6,299 | 6,374 | +14 | +0.2% | 1,087,600 |
2019/05/22 | 6,395 | 6,429 | 6,353 | 6,360 | -62 | -1% | 891,000 |
2019/05/21 | 6,415 | 6,534 | 6,413 | 6,422 | +7 | +0.1% | 1,017,300 |
1301~
1350
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム